---
document_datetime: 2023-09-21 19:52:30
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/fexeric-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: fexeric-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4892569
conversion_datetime: 2025-12-22 10:17:57.33475
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Fexeric

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary                           |
|----------------------|-------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|-----------------------------------|
| PSUSA/10418 /201903  | Periodic Safety Update EU Single assessment - ferric citrate coordination complex product | 03/10/2019                          | n/a                                            |                                  | PRAC Recommendation - maintenance |
| T/0015               | Transfer of Marketing Authorisation                                                       | 21/08/2019                          | 09/09/2019                                     | SmPC, Labelling and PL           |                                   |
| PSUSA/10418 /201809  | Periodic Safety Update EU Single assessment - ferric citrate coordination complex         | 11/04/2019                          | n/a                                            |                                  | PRAC Recommendation - maintenance |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

edicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| PSUSA/10418 /201803   | Periodic Safety Update EU Single assessment - ferric citrate coordination complex                                                                                                                                                                                                                                                                                                                                                                          | 04/10/2018   | n/a                       | PRAC Recommendation - maintenance   |
|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|-------------------------------------|
| PSUSA/10418 /201709   | Periodic Safety Update EU Single assessment - ferric citrate coordination complex                                                                                                                                                                                                                                                                                                                                                                          | 12/04/2018   | n/a                       | PRAC Recommendation - maintenance   |
| PSUSA/10418 /201703   | Periodic Safety Update EU Single assessment - ferric citrate coordination complex                                                                                                                                                                                                                                                                                                                                                                          | 26/10/2017   | n/a                       | PRAC Recommendation - maintenance   |
| PSUSA/10418 /201609   | Periodic Safety Update EU Single assessment - ferric citrate coordination complex                                                                                                                                                                                                                                                                                                                                                                          | 06/04/2017   | n/a                       | PRAC Recommendation - maintenance   |
| IB/0007               | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                              | 12/10/2016   | 07/09/2017 SmPC no longer | and Annex II                        |
| PSUSA/10418 /201603   | Periodic Safety Update EU Single assessment - ferric citrate coordination complex                                                                                                                                                                                                                                                                                                                                                                          | 29/09/2016   | n/a                       | PRAC Recommendation - maintenance   |
| IB/0005/G             | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary product | 12/06/2016   | n/a                       |                                     |

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             | packaging, for non-sterile medicinal products B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                           | longer            |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------|
| IA/0004     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 11/03/2016 n/a    |
| IA/0003/G   | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size product | 08/02/2016 n/a no |
| IAIN/0002/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 22/12/2015 n/a    |

edicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

|           | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition   | longer     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| IA/0001/G | This was an application for a group of variations. B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition  | 04/12/2015 |

<!-- image -->

04/12/2015 n/a edicinal product no longer authorised